NDC 69097-850

daptomycin

Daptomycin

daptomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Daptomycin.

Product ID69097-850_219e8987-0f88-4149-80e3-77d97e555791
NDC69097-850
Product TypeHuman Prescription Drug
Proprietary Namedaptomycin
Generic NameDaptomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-03-26
Marketing CategoryANDA /
Application NumberANDA213425
Labeler NameCipla USA Inc.
Substance NameDAPTOMYCIN
Active Ingredient Strength350 mg/7mL
Pharm ClassesLipopeptide Antibacterial [EPC],Lipopeptides [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69097-850-67

1 VIAL in 1 CARTON (69097-850-67) > 7 mL in 1 VIAL
Marketing Start Date2021-03-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "daptomycin" or generic name "Daptomycin"

NDCBrand NameGeneric Name
0143-9378DaptomycinDaptomycin
0409-0106DaptomycinDAPTOMYCIN
0409-0120DaptomycinDAPTOMYCIN
0409-0122DaptomycinDAPTOMYCIN
0409-2757DaptomycinDAPTOMYCIN
0409-5933DaptomycinDaptomycin
0703-0125DaptomycinDaptomycin
0781-3295daptomycindaptomycin
16714-892DaptomycinDaptomycin
16729-434DaptomycinDaptomycin
16729-435DAPTOMYCINDaptomycin
25021-174daptomycindaptomycin
25021-179DaptomycinDaptomycin
70594-034DaptomycinDaptomycin
70594-053DaptomycinDaptomycin
63323-871DaptomycinDaptomycin
63323-371DaptomycinDaptomycin
67457-813daptomycindaptomycin
43598-413DaptomycinDaptomycin
68001-376DaptomycinDaptomycin
63323-585DaptomycinDaptomycin
71839-107daptomycindaptomycin
57884-3151DaptomycinDaptomycin
69097-807DaptomycinDaptomycin
72572-102DaptomycinDaptomycin
72572-100DaptomycinDaptomycin
45932-0039DaptomycinDaptomycin
71288-018DAPTOMYCINDAPTOMYCIN
76233-091DaptomycinDaptomycin
31722-102DaptomycinDaptomycin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.